Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

charges ($5.4 million, or $0.44 per share tax-effected), related to

the sale of the Company's endovascular business during the fourth

quarter of fiscal year 2008.

Note: To supplement our consolidated financial statements presented in

accordance with GAAP, Kensey Nash Corporation uses non-GAAP measures

of adjusted earnings per share, which are adjusted from our GAAP

results to exclude certain expenses. These non-GAAP adjustments are

provided to enhance the user's overall understanding of our

historical and current financial performance and our prospects for

the future. We believe the non-GAAP results provide useful

information to both management and investors by excluding certain

expenses that we believe are not indicative of our core operating

results.

These non-GAAP measures will provide investors and management with

an alternative method for assessing Kensey Nash's operating results

in a manner consistent with future presentation. Further, these

non-GAAP results are one of the primary indicators management uses

for planning and forecasting in future periods. The presentation of

this additional information should not be considered in isolation or

as a substitute for results prepared in accordance with accounting

principles generally accepted in the United States.

Supplemental Non-GAAP Financial Measures and Reconciliations

Kensey Nash Corporation

Non-GAAP Financial Measures and Reconciliations

Adjusted Income and Earnings Per Share Reconciliation

(Unaudited) (Unaudited)

As Reported Non-GAAP Adjustments As Adjusted

Three Emboli
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Fluorinov Pharma (Fluorinov), a FACIT portfolio company, today announced ... its Board of Directors.  His appointment strengthens Fluorinov,s leadership ... accelerates its clinical development activities.  "On ... to welcome Luke to the Board of Directors.  Luke ... strength and success of multiple organizations," said Malik ...
(Date:5/26/2015)... SYDNEY and NEW YORK , May ... Limited (ASX:NRT; NASDAQ: NVGN ), announced today that it will ... May 28, 2015 in New York City ... by Dr. Graham Kelly , Novogen Chairman and CEO, is ... via a live webcast. To access the webcast, go to ...
(Date:5/26/2015)... May 26, 2015 Just the characterization ... long-standing unmet biomedical need does not guarantee immediate acceptance. ... that has seen many prior failures is often met ... and use is an irony that is often an ... new start-up company, Asymmetrex has found that ...
(Date:5/25/2015)... FL (PRWEB) May 26, 2015 Where ... speaker Jack Uldrich says, "The honest answer is that ... deliver four keynote speeches throughout the month of June, ... keynote topics vary from future-proofing to top tech trends. ... Uldrich's research is where the universe is expanding to. ...
Breaking Biology Technology:Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 2Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors 3Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 2Futurist Jack Uldrich Says Embracing Our Ignorance is the Key to Unlearning 3
... , COLUMBIA, Md., Dec. 2 ... intends to release the results of its fourth quarter and fiscal ... Time (ET). Following the release, at 4:45 p.m. ET Martek ... All interested parties may listen to the call live via ...
... , NEW YORK, ... research report is available in its catalogue: , ... http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html , The world neurostimulation market stands ... the resultant rise in age-related diseases such as, Parkinson,s, ...
... , NEW ... market research report is available in its catalogue: , ... Market Trends & Opportunities , http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ... element of every pharmaceutical company,s business strategy. There are ...
Cached Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
(Date:5/19/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/18/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
(Date:5/11/2015)... SAN JOSE, Calif. , May 11, 2015 ... leading developer of human interface solutions, today announced ... Senior Vice President and Chief Financial Officer, reporting ... Mr. Ali replaces Synaptics, current Chief Financial Officer, ... in December 2014. Mr. Ali ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... group of fruit flies invading their kitchen, it probably appears ... treat. But a closer look would likely reveal the male ... fight, particularly if ripe fruit or female flies are present. ... California Institute of Technology (Caltech) biologist David Anderson, male ...
... fibromyalgia syndrome (FMS) typically have widespread chronic pain and ... D supplements can reduce pain and may be a ... in the current issue of PAIN . ... FMS may experience sleep disorders, morning stiffness, poor concentration, ...
... paper details a collaboration between the National Park Service ... Society (WCS) scientists, in developing recommendations to ... that move in and out of U.S. national parks, ... paper, "Optimism and Challenge for Science-based Conservation of Migratory ...
Cached Biology News:Fighting flies 2Fighting flies 3Fighting flies 4Vitamin D supplements reduce pain in fibromyalgia sufferers 2National Park Service and outside experts collaborate to conserve migratory wildlife 2National Park Service and outside experts collaborate to conserve migratory wildlife 3
... fragment is a proteolytic product ... DNA Polymerase I which retains ... exonuclease activity, but has lost ... retains the polymerization fidelity of ...
Request Info...
ANTI STENOTROPHOMONAS MALTOPHILIA...
... The Pro upgrade for Shimadzu Phoretix 2D, ... advanced statistical tools for comparative gel analysis ... Data base add on component ... (Oracle version 9i release 2 client software). ...
Biology Products: